SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001267602-22-000054
Filing Date
2022-12-08
Accepted
2022-12-08 16:09:04
Documents
14
Period of Report
2022-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alim-20221207x8k.htm   iXBRL 8-K 72472
2 EX-99.1 alim-20221207xex99_1.htm EX-99.1 16335
3 GRAPHIC alim-20221207xex99_1g001.jpg GRAPHIC 55720
  Complete submission text file 0001267602-22-000054.txt   293427

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20221207.xsd EX-101.SCH 2167
5 EX-101.LAB alim-20221207_lab.xml EX-101.LAB 18361
6 EX-101.PRE alim-20221207_pre.xml EX-101.PRE 11525
8 EXTRACTED XBRL INSTANCE DOCUMENT alim-20221207x8k_htm.xml XML 4813
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 221452492
SIC: 2834 Pharmaceutical Preparations